The COVID-19 Imaging Research Registry (CIRR) will advance medical science’s understanding, prevention and treatment of coronavirus (COVID-19). The registry fosters integration and knowledge sharing across the clinical research community, representing clinical medicine, genetics, biomarker discovery and laboratory sciences.
The ACR will collect images and data performed as part of routine clinical care in diagnosing and treating COVID-19 patients in the U.S. since January 1, 2020. Participating sites will contribute demographic information, clinical data on signs and symptoms, imaging exams, laboratory test data and outcomes. The data collected will be used for educational purposes, AI algorithm development and research studies. A subset of the full CIRR dataset will be de-identified and made publicly available via the Medical Imaging and Data Resource Center (MIDRC).
MIDRC is a collaboration among the nation’s largest medical imaging associations: ACR, American Association of Physicists in Medicine (AAPM), and the Radiological Society of North America (RSNA). Read more about ACR’s participation in MIDRC.
The ACR is working with the Centers for Medicare and Medicaid Services to allow clinicians to earn credit under the Merit-based Incentive Payment System (MIPS) by contributing data to the CIRR. Sites that contribute data will have access to their data and will be eligible to request data for other COVID-19 research projects, subject to IRB approval and the oversight of the CIRR Steering Committee.
Data collection for CIRR is now live.